Response to 'Intermittent androgen blockade should be regarded as standard therapy in prostate cancer'

Nat Clin Pract Oncol. 2009 Feb;6(2):E1. doi: 10.1038/ncponc1317.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Androgen Antagonists / administration & dosage*
  • Androgen Antagonists / standards*
  • Animals
  • Cell Line, Tumor
  • Drug Administration Schedule
  • Humans
  • Male
  • Mice
  • Mice, Nude
  • Prostatic Neoplasms / blood
  • Prostatic Neoplasms / drug therapy
  • Prostatic Neoplasms / pathology
  • Xenograft Model Antitumor Assays / methods

Substances

  • Androgen Antagonists